Results 21 to 30 of about 106,214 (290)

Nutrition in the Era of Highly Active Antiretroviral Therapy [PDF]

Clinical Infectious Diseases, 2001
Despite tremendous advances in treatment, persons with human immunodeficiency virus (HIV) infection commonly experience a variety of nutritional problems, such as weight loss, fat redistribution, and obesity. We discuss basic dietary and metabolic problems as they pertain to persons with HIV infection and provide practical suggestions for their ...
A H, Shevitz, T A, Knox
openaire   +2 more sources

Positive Outcomes of HAART at 24 Months in HIV-Infected Patients in Cambodia. [PDF]

, 2007
OBJECTIVES: African and Asian cohort studies have demonstrated the feasibility and efficacy of HAART in resource-poor settings. The long-term virological outcome and clinico-immunological criteria of success remain important questions.
Bartlett, Bartlett, Bourgeois, Calmy, Calmy, Carrieri, Carrieri, Coetzee, Colebunders, Colebunders, Dabis, Ferradini, Gill, Gonzalez de, Grabar, Ivers, Kumarasamy, Laurent, Laurent, Lawn, Lawn, Lawn, Le Moing, Ly, Madec, Marzolini, Orrell, Pasquier, Rouet, Rouzioux, Severe, Tassie, Van Heeswijk, Weidle, Wu, Zhou   +35 more
core   +2 more sources

Daily Dosing of Highly Active Antiretroviral Therapy [PDF]

Clinical Infectious Diseases, 2002
Complex treatment schedules for human immunodeficiency virus (HIV) disease, which can have a high pill burden and can include multiple daily doses, in addition to the adverse effects that the medications can cause, may reduce patient adherence to therapy. Reduced adherence prevents achievement of the desired goal of full suppression of HIV replication,
Keith A, Rosenbach, Robert, Allison, Jeffrey P, Nadler   +2 more
openaire   +2 more sources

HAART (Highly Active Anti-Retroviral Therapy) : An overview

Journal of Marine Medical Society, 2014
Highly Active Anti - Retroviral Therapy (HAART) is a triple combination of ART drugs and is a n effective tool to control disease progression in HIV disease.
Praful Pande, Vivek Hande
doaj   +1 more source

Duration of Highly Active Antiretroviral Therapy Regimens [PDF]

Clinical Infectious Diseases, 2003
The median duration of highly active antiretroviral therapy (HAART) regimens was reported to be 11.8 months in one US study, but that study included both treatment-experienced and treatment-naive patients. The duration of initial HAART regimens for treatment-naive patients alone has not been reported.
Ray Y, Chen, Andrew O, Westfall, Michael J, Mugavero, Gretchen A, Cloud, James L, Raper, Ashlee G, Chatham, Edward P, Acosta, Kelly H, Taylor, Jerome, Carter, Michael S, Saag   +9 more
openaire   +2 more sources

Antiretroviral agents against human immunodeficiency virus

DST, 2022
Introduction: Since its discovery in the 1980s, the human immunodeficiency virus (HIV) has been the target of many studies. Nowadays, estimates show that 36.7 million people are infected with HIV worldwide.
Ingrid Barcelos de Oliveira, Claudio Cesar Cirne Santos, Izabel Christina Nunes de Palmer Paixão, Caroline de Souza Barros, Rosa Teixeira Pinho   +4 more
doaj  

Stereoselective Biotransformation: Transfer of Learning to Advance Drug Metabolism and Biocatalysis

Angewandte Chemie, EarlyView.
Understanding stereoselective biotransformations has implications for predicting drug disposition and response and may also inspire novel biocatalytic and biomimetic strategies to address challenges in metabolite and API synthesis. ABSTRACT Chirality is an important determinant of drug action, as enantiomers can exhibit markedly different ...
Grace A. Okunlola, Godwin A. Aleku
wiley   +2 more sources

Highly Active Antiretroviral Therapy (HAART) [PDF]

Journal of Ethiopian Medical Practice, 2001
No Abstract. Journal of Ethiopian Medical Journal Vol. 3(2) 2002: pp.
Daniel Thomas Ginat, Pamela Whitney Schaefer   +1 more
openaire   +3 more sources

Excess mortality and associated factors among people living with HIV initiating highly active antiretroviral therapy in Luzhou, China 2006–2020

BMC Infectious Diseases, 2023
Background To estimate crude mortality, excess mortality, and standardized mortality rates (SMR) among people living with HIV (PLHIV) initiating highly active antiretroviral therapy (HAART) in Luzhou, China 2006–2020, and assess associated factors ...
Dandan Niu, Ticheng Xiao, Yuanyi Chen, Houlin Tang, Fangfang Chen, Chang Cai, Qianqian Qin, Decai Zhao, Yichen Jin, Shi Wang, Yushan Hou, Zhen Lu, Luoyao Yang, Hong Liu, Dongqin Xie, Huachun Zou, Fan Lyu   +16 more
doaj   +1 more source

Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries [PDF]

, 2009
BACKGROUND: In developing countries, access to laboratory tests remains limited, and the use of simple tools such as weight to monitor HIV-infected patients treated with antiretroviral therapy should be evaluated.
Arnaud Fontanet, Bagchi, Bisson, Bonard, Bonnet, Calmy, Christine Genevier, Diggle, Elisabeth Szumilin, Erikstrup, Etard, Ferradini, Ferradini, Gilks, Harries, Ivers, Jerene, Laurent Ferradini, Madec, Malvy, Mar Pujades, Paton, Saghayam, San Lio, Severe, Shetty, Shikuma, Silva, Spacek, Stringer, Suna Balkan, Tang, Van Damme, Yoann Madec   +33 more
core   +3 more sources